Nestlé Recalls Baby Formula in 37 Markets Over Toxin Risk
Listen to the full version

Swiss food giant Nestlé S.A. has initiated a global recall of infant formula products in China and 36 other markets over concerns about a potentially harmful ingredient.
The company said the precautionary move was triggered by traces of a toxin, produced by the bacterium Bacillus cereus, detected in arachidonic acid oil (ARA), a component used in baby formula. While no illnesses have been reported, the contaminant — capable of causing vomiting and diarrhea — prompted a swift withdrawal of select batches.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- DIGEST HUB
- Nestlé recalled infant formula in China and 36 other markets due to Bacillus cereus toxin detected in ARA oil, affecting under 0.5% of annual sales.
- No illnesses have been reported; the recall is precautionary and involves several brands, including Lactogen, NAN Pro, Alfamino, and Wyeth S-26 Progress.
- For the first nine months of 2025, Nestlé reported CHF 65.9 billion ($83.5 billion) revenue, a 3.3% year-over-year increase.
- Nestlé S.A.
- Nestlé S.A., a Swiss food giant, initiated a global recall of infant formula due to a potentially harmful toxin, Bacillus cereus, in arachidonic acid oil (ARA). This precautionary measure affected products in China and 36 other markets, even though no illnesses were reported. The recall concerns less than 0.5% of annual sales, with minimal financial impact. Affected brands in China include Lactogen, NAN Pro, Alfamino, and Wyeth S-26 Progress.
- MOST POPULAR





